3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
4
Uterine Cervical Neoplasms
3
Ganglioneuroblastoma
3
Sarcoma, Ewing
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neuroblastoma
2
Vaginal Neoplasms
1
Stomach Neoplasms
1
Stage I Prostate Adenocarcinoma AJCC v7
1
Squamous Cell Carcinoma of Head and Neck
1
Polycystic Ovary Syndrome
1
Oropharyngeal Neoplasms
1
Multiple Myeloma
1
Locally Advanced Cervical Adenocarcinoma
1
Infertility
1
Human Papillomavirus-Negative Neck Squamous Cell Carcinoma
1
Cholangiocarcinoma
1
Cervical Adenocarcinoma
1
Carcinosarcoma
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Biochemically Recurrent Prostate Carcinoma
1
Adenocarcinoma Of Esophagus
1
Interventions
Specimen Handling
3
olaparib
2
durvalumab
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Ipilimumab
2
CTLA-4 Antigen
2
serabelisib
1
sapanisertib
1
defactinib
1
ceralasertib
1
cediranib
1
capivasertib
1
cabozantinib
1
Restraint, Physical
1
RO5126766
1
Paclitaxel
1
Immunoglobulin G
1
Hysterectomy
1
Fluid Therapy
1
Disulfides
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Endometrioid
×
Congresses as Topic
×
1 year
×
Clear all
No trials found.